Wednesday, september 11

15:00h Opening welcome ceremony



SYMPOSIUM 1 – Importance of metabolic balance in the control of neuroendocrine system 



  • Cardiometabolic actions of GH
    Peter Wolf,
     Division of Endocrinology & Metabolism. Department of Internal Medicine III. Medical University of Vienna (Austria) 
  • Crosstalk between GH and metabolism
    Rhonda Kineman,
    Division of Endocrinology, Diabetes and Metabolism. Department of Medicine. University of Illinois at Chicago (USA) 
  • Metabolic effects of dopamine receptor signaling and inhibition: translational studies
    Graciela Diaz-Toga, Vicedirectora del Instituto de Biología y Medicina Experimental Directora del Laboratorio de Fisiopatología Hormonal IBYME-CONICET. Buenos Aires. (Argentina)
  • Metabolic impact of dopamine agonists: clinical studies
    Renata Auriemma,
    Department of Clinical Medicine and Surgery. University ‘Federico II’. Naples (Italy)
17:55-18:20 Coffee break and Posters
18:20-19:00 ENEA studies

SYMPOSIUM 2 Turkey Prolactin: From prolactinomas to non-classical effects 



  • Prolactin and autoimmunity: is it an inflammatory cytokine?
    Pinar Kadioglu,
    Department of Endocrinology-Metabolism and Diabetes. Cerrahpaşa Medical Faculty. İstanbul. (Turkey) 
  • Prolactin and its receptor in breast cancer
    Hasan Fahrettin Keleştemur,
    Yeditepe University. Medical School. Department of Endocrinology. İstanbul. (Turkey)
  • Prolactin and coagulation
    Aysegul Atmaca,
    Ondokuz Mayis University School of Medicine. Samsun. (Turkey)
20:15-20:45 ENEA General Assembly
21:30 Networking cocktail

Thursday, september 12

Morning sessions
08:00-08:45h Industry-sponsored symposium 1

Meet-the-Expert clinical-1


  • The transition age in sellar and parasellar lesion
    Emilia Sbardella, Department of Experimental Medicine. Faculty of Medicine and Dentistry, Sapienza University of Rome. Italy

Meet-the-Expert clinical-2

  Parallel Room 1

  • From congenital to acquired hypogonadotropic hypogonadism: developmental and therapeutical perspectives
    Jacques Young, Department of Reproductive Endocrinology and Reference. Center for Rare Pituitary Diseases, University Paris-Saclay. Assistance Publique – Hôpitaux de Paris. France

Meet-the-Expert Basic/Traslational-1

  Parallel Room 2

  • Use of organoids for disease modeling
    Nuria Montserrat, Institute for Bioengineering of Catalonia. Barcelona. (Spain)

The Year in Neuroendocrinology


  • The year in Neuroendocrinology – Basic
    Speaker to be confirmed
  • The year in Neuroendocrinology – Clinical
    Martin Reincke. Department of Medicine 4, LMU Klinikum. Ludwig- Maximilians-University Munich (Germany)

10:15-11:45 PLENARY 2 Underpinnings of the sex bias in pituitary pathology

  • Sex differences in pituitary pathologies
    Mónica Marazuela, Autonomous University of Madrid. Princesa Hospital. Madrid. (Spain)

10:45-11:15 Coffee break and Posters

SYMPOSIUM 3 Crosstalk of neuroendocrine signals and fertility


  • Hypothalamo-pituitary ovarian axis (HPO) in female mammals
    Joëlle Dupont, Department of Animal Physiology and Livestock Systems. French National Institute for Agriculture, Food, and Environment. París. (France)
  • AMH as neuroendocrine hormone
    Manuel Tena-Sempere, Faculty of Medicine and Instituto Maimónides de Investigación Biomedica de Córdoba (IMIBIC). University of Córdoba. Spain
  • Neuroendocrine dysfunction in PCOS
    Bulent O. Yildiz, Division of Endocrinology and Metabolism. Department of Internal Medicine. Hacettepe University School of Medicine. Ankara. (Turkey)
12:30-13:45 SYMPOSIUM 4 Hypothalamic syndrome

  • Developmental neurobiology of the hypothalamus
    Marysia Placzek, Professor of Developmental Neurobiology. University of Sheffield. (UK)
  • (Neuro) endocrinology of hypothalamic síndrome
    Eva-Marie Erfurth. Cinical Endocrinologist Adjunct professor at Medicine. Lund University. (Sweden)
  • Diagnostic criteria and risk adapted treatment approaches
    HM van Santen. Pediatric Endocrinologist and Associate Professor. University Medical Center Utrecht. (Netherlands)
13:45-14:30 Industry-sponsored symposium 2
14:30-15:15h Posters
  (LUNCH starting at 13:45)

Meet-the-Expert clinical-3



  • Case-based approach in AVP deficiency
    Emanuele Ferrante,
    UOC Endocrinology. Foundation IRCCS Ca’ Granda Maggiore Polyclinic Hospital of Milan (Italy)

Meet-the-Expert clinical-4


Parallel Room 1

  • Transcriptomics analyses on aggressive pituitary adenomas and craniopharyngioma
    Gerald Raverot, Hospices Civils of Lyon. Lyon 1 University. Lyon (France)

Meet-the-Expert Basic/Traslational-2


Parallel Room 2

  • Brain-Bone axis
    Giovanni Lombardi, Director of the Laboratory of Experimental Biochemistry & Molecular Biology at the IRCCS Istituto Ortopedico Galeazzi Milan. (Italy)


17:00-17:30 Coffee break and Posters
17:30-18:30 EYRC SYMPOSIUM 5 Hot topic in neuroendocrinology: from bench to beside

  • Oxytocin deficiency – does it exist, how to test for it, and is there any treatment available?
    Cihan Atila, Department of Endocrinology, Diabetes & Metabolism. Department of Clinical Research. University Hospital Basel. (Switzerland)
  • Obesity and endocrine-related cancers: unraveling the heavy burden
    Juan M Jiménez-Vacas, Postdoctoral Researcher at The Institute of Cancer Research. London (UK)
  • Differences between GH and PRL co-secreting and GH-secreting pituitary adenomas
    Marta Araujo-Castro, Neuroendocrinology & Adrenal Unit of the Endocrinology & Nutrition Department. Hospital Universitario Ramón y Cajal. Madrid. (Spain)

SYMPOSIUM 6 Harmony within: unraveling the dance of the pituitary gland and the systemic milieu



  • Diagnosing pituitary deficiency and excess in the absence of (or whitout) GHRH and CRH
    Michal Kršek, 3rd Department of Medicine – Department of Endocrinology and Metabolism Charles University in Prague. (Czech Republic)
  • Long-term Metabolic Impact of Changes in Adipose Tissue Depots after Treatment of Acromegaly
    Cristina Olarescu, Section of Specialized Endocrinology, Department of Endocrinology, Oslo University Hospital. Oslo (Norway)
  • Effect of exogeneous opioids on the pituitary
    Monica Gadelha, Professor of Endocrinology. Federal University of Rio de Janeiro (Brasil)

Friday, september 13

Morning sessions



Industry-sponsored symposium 3



Meet-the-Expert clinical-5



  • Cushioning the Blow: Navigating Clinical Complications in Cushing’s Disease
    Katharina Schilbach, Consultant Endocrinologist. Medical Clinic and Polyclinic IV, LMU Hospital. Munich (Germany)

Meet-the-Expert clinical-5


  • Cushioning the Blow: Navigating Clinical Complications in Cushing’s Disease
    Katharina Schilbach, Consultant Endocrinologist. Medical Clinic and Polyclinic IV, LMU Hospital. Munich (Germany)

Meet-the-Expert clinical-6

Parallel Room 1

  • Clinical approach to hiponatremia
    Speaker to be confirmed

Meet-the-Expert Basic/Traslational-3

Parallel Room 2

  • Importance of stem cells to study neuroendocrine pathologies
    Cynthia Andoniadou, Reader in Stem Cell Biology and Associate Dean for Postgraduate Research at King’s College London (UK)

PLENARY 3 50 year of the discovery of somatostatin



  • 50 year of the discovery of somatostatin
    Shlomo Melmed, Executive Vice President of Medicine and Health Sciences. Dean of the Medical Faculty. Cedars-Sinai Medical Center. Los Angeles (CA)

SYMPOSIUM 7 Uncharted territories: novel perspectives in pituitary tumor management 



  • Psychological complications of Cushing’s syndrome
    Alicia Santos, Endocrinology Department. Hospital Sant Pau. Centre for Biomedical Research Network of Rare Diseases (CIBERER747). IIB-Sant Pau. ISCIII and Autonomous University of Barcelona. (Spain)
  • Acromegaly, psycological and neurocognitive impairment: what do we know today?
    Rosario Pivonello, Professor Endocrinology, University Federico II of Naples. (Italy)
  • Drug resistance in pituitary tumours: from cell membrane to intracellular signaling
    Erika Peverelli, Department of Clinical Sciences and Community Health. University of Milan. (Italy)
  • The Spanish Molecular Registry of Pituitary Tumours (REMAH): a network aimed at improving patient management
    Aura Herrera, Endocrinology and Nutrition Unit. Reina Sofia University Hospital. Maimonides Biomedical Research Institute of Cordoba. Córdoba (Spain)
11:40-12:15 Coffee break and Posters


SYMPOSIUM 8 Novel mechanisms involved in the control of the gene and protein expression in neuroendocrine pathologies



  • Splicing makes the difference in health and disease
    Speaker to be confirmed
  • Importance of epigenetic changes in neuroendocrine tumors: from tumor biology to clinical application
    Speaker to be confirmed
  • MicroRNAs as biomarkers for the diagnosis and treatment of neuroendocrine diseases
    Laura Garcia-Bermejo, Scientific Director at Ramon & Cajal Health Research Institute. Madrid (Spain)



Industry-sponsored symposium 4

Auditorium (Lunch)




(Lunch starting at 13:30)






  • An overview on the current neuro-surgical approaches for Sella Turcica
    Eugenio Cárdenas, Neurosurgeon,
    University Hospitals Virgen del Rocío and Virgen Macarena. Sevilla (Spain)
Parallel Room 1

  • Systemic therapies against papillary and adantinomatous craniopharyngioma
    Darren Hargrave, Professor at UCL Great Ormond Street Institute of Child Health. London (UK)

Parallel Room 2

  • Sex-specifc effects of stress in the hypothalamus, using single-cell transcriptomics
    Elena Brivio, Institute of Genetics and Molecular and Cellular Biology. Illkirch. (France)



Oral Communications 2

  Oral Communications 3
Parallel Room 1
  Oral Communications 4
Parallel Room 2

SYMPOSIUM 9 – Exploring the mind-body nexus


Parallel Room 1

  • Soma-psyche interaction
    Eva Reininghaus,
    Medical University of Graz. University Clinic of Psychiatry, Psychosomatics and Psychotherapy. Clinical Division of Psychiatry and Psychotherapeutic Medicine. Graz (Austria)
  • New biomarkers of stress
    Eva MJ Peters,
    Head of Psychoneuroimmunology Laboratory. Giessen University. Giessen (Germany)
  • Cell-Type-Specific Impact of Glucocorticoid Receptor Activation on the Developing Brain
    Cristiana Cruceanu,
    Department of Physiology and Pharmacology Karolinska Institutet. Stockholm. (Sweden)
17:45-18:15h Coffee break and Posters
18:15-18:45h PLENARY 4


  • GnRN as novel treatment to improve neurocognitive function
    Nelly Pittleoud,
    Chief of Endocrinology, Diabetes and Metabolism Service. Lausanne. (Switzerland)

Closing ceremony & prices